(Total Views: 520)
Posted On: 07/26/2023 12:27:28 AM
Post# of 149219
Quote:
My understanding was that the 'AI capable partner' was for the purpose of developing a longer term therapeutic for Leronlimab... (not to find more indications to pursue)
You are correct. I should have listened to the CC first. Extending patent protection would also have the benefit of assuring any partners of a long runway for the drug.
(5)
(0)Scroll down for more posts ▼
